The Documentation About "Codex Alimentarius"

How does the Codex Alimentarius Commission work?

The Codex Commission on Nutrition and Foods for Special Dietary Uses has, since the year 2000, met every year. As the Government of the German Federal Republic is in charge of this committee, these meetings usually occur on German soil. In 1996, the meeting took place in Bonn and in 1998, 2000, 2001 and 2002 in Berlin. The meeting returns to Bonn in 2003.

The Codex procedure to establish resolutions takes eight steps - starting with the deliberation stage, moving through the recommendation stage and finally reaching the decision stage. Because of a massive protest in June 2000 and again in November 2001 and November 2002, we stopped the Codex procedure at stage three.

At present, the pharmaceutical cartel is preparing to execute the final five stages in one step during the next meeting. This would mean that the Codex conference of November 2003 will recommend that all member nations confirm the vitamin censure laws.

Examining the composition of this Codex commission explains how such nefarious plans can be spawned in a panel of the United Nations.

More than half of all Codex members receive money from the pharmaceutical industry. If you now add those politicians who depend on salaries or bribes from the pharmaceutical industry, the imbalance becomes clear: more than three quarters of the Codex Alimentarius members represent the interests of the pharmaceutical industry.

To grant superficial legitimacy to the proceedings, the pharmaceutical groups include "Consumer Protection" organizations (which have been created by the pharmaceutical companies themselves) in the Codex commission. The best-known examples are the German Association for Nutrition (DGE) and the US Council for Responsible Nutrition (CRN).

The governments of smaller European countries and developing nations face economic blackmail from the international pharmaceutical groups. Only months after the Swiss group Novartis (formerly Sandoz and Ciba Geigy) moved its head quarters to Norway, the Norwegian government supported the Codex plans. Where subsidiaries of multi-national pharmaceutical groups settle depends largely on a government's attitude toward certain policies within the framework of the UNO - i.e. "Codex".